Skip to main content
. 2022 Sep 26;14(19):4682. doi: 10.3390/cancers14194682

Figure 3.

Figure 3

Percentage distribution of sensitive and cisplatin- and gemcitabine-resistant TCCSUP and RT112 cells undergoing early apoptosis (lower right quadrants), late apoptosis (upper right quadrants), and necrosis (upper left quadrants). Vital cells are presented in the lower left quadrants. The percentage of cells is included in each quadrant. One representative of 3 analyses (intra-assay SD <10%).